KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) FCF Margin (2016 - 2025)

Historic FCF Margin for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to 6.02%.

  • Fulgent Genetics' FCF Margin rose 548600.0% to 6.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.29%, marking a year-over-year increase of 40300.0%. This contributed to the annual value of 6.79% for FY2024, which is 84500.0% down from last year.
  • As of Q3 2025, Fulgent Genetics' FCF Margin stood at 6.02%, which was up 548600.0% from 45.23% recorded in Q2 2025.
  • Fulgent Genetics' 5-year FCF Margin high stood at 65.3% for Q3 2021, and its period low was 48.85% during Q3 2024.
  • Its 5-year average for FCF Margin is 13.03%, with a median of 6.28% in 2023.
  • In the last 5 years, Fulgent Genetics' FCF Margin skyrocketed by 755500bps in 2021 and then plummeted by -721800bps in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' FCF Margin stood at 28.25% in 2021, then soared by 49bps to 42.07% in 2022, then tumbled by -60bps to 16.77% in 2023, then skyrocketed by 66bps to 27.87% in 2024, then plummeted by -78bps to 6.02% in 2025.
  • Its FCF Margin was 6.02% in Q3 2025, compared to 45.23% in Q2 2025 and 12.45% in Q1 2025.